It has been recently reported in lung adenocarcinoma patients and a tumor cell injection model that activated KRAS signaling triggers CD47 expression on tumor cells inhibiting their phagocytotic elimination45. The gene discussed is KRAS; the disease is lung adenocarcinoma.